Literature DB >> 32195510

Selenolesterase enzyme activity of carbonic anhydrases.

Andrea Angeli1, Fabrizio Carta, Selene Donnini, Antonella Capperucci, Marta Ferraroni, Damiano Tanini, Claudiu T Supuran.   

Abstract

Carbonic anhydrases (CAs, E.C. 4.2.1.1) are metalloenzymes expressed on a variety of cell types. Their overexpression leads to serious pathologies, including cancer. The discovery of a series of selenolesters with high structural diversity as novel CA inhibitors is reported here. These compounds show remarkable in vitro inhibition against a panel of human CA isoforms such as hCA I, II, IX and XII. We observed that they undergo a CA mediated hydrolysis, releasing different active selenol fragments, which act as CA inhibitors. Notably, to the best of our knowledge, this is the first example of an enzyme with selenolesterase activity. In addition, X-ray crystallographic data support the proposed mechanism, proving selenolesters as novel pro-drug inhibitors with potential pharmacological applications.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32195510     DOI: 10.1039/d0cc00995d

Source DB:  PubMed          Journal:  Chem Commun (Camb)        ISSN: 1359-7345            Impact factor:   6.222


  3 in total

Review 1.  The Role of Selenium in Pathologies: An Updated Review.

Authors:  Giulia Barchielli; Antonella Capperucci; Damiano Tanini
Journal:  Antioxidants (Basel)       Date:  2022-01-27

2.  Glyco-Coated CdSe/ZnS Quantum Dots as Nanoprobes for Carbonic Anhydrase IX Imaging in Cancer Cells.

Authors:  Giacomo Biagiotti; Andrea Angeli; Arianna Giacomini; Gianluca Toniolo; Luca Landini; Gianluca Salerno; Lorenzo Di Cesare Mannelli; Carla Ghelardini; Tommaso Mello; Silvia Mussi; Cosetta Ravelli; Marcello Marelli; Stefano Cicchi; Enzo Menna; Roberto Ronca; Claudiu T Supuran; Barbara Richichi
Journal:  ACS Appl Nano Mater       Date:  2021-11-17

3.  Selenocarbamates As a Prodrug-Based Approach to Carbonic Anhydrase Inhibition.

Authors:  Andrea Angeli; Marta Ferraroni; Antonella Capperucci; Damiano Tanini; Gabriele Costantino; Claudiu T Supuran
Journal:  ChemMedChem       Date:  2022-03-23       Impact factor: 3.540

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.